Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors
PARIS, FRANCE / ACCESSWIRE / July 11, 2023 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune...